Current perspectives on anal cancer

ONCOLOGY

Volumn 17, Issue 4, 2003, Pages

  Bendell, Johanna C ^a   Ryan, David P ^b  

^a Dana Farber/Partners CancerCare   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANUS TUMOR; CANCER STAGING; HUMAN; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING;

EID: 0037658668     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5- 26, 2003.
2. Palefsky JM: Anal human papillomavirus infection and anal cancer in HIV-positive individuals: An emerging problem'. AIDS 8:283-295, 1994.
3. Greenlee RT, Hill-Harmon MB, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 51:15-36, 2001.
4. Melbye M, Cote TR, Kessler L, et al: High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 343:636-639, 1994.
5. Myerson RJ, Karnell LH, Menck HR: The National Cancer Data Base report on carcinoma of the anus. Cancer 80:805-815, 1997.
6. Klotz RG Jr, Pamukcoglu T, Souilliard DH: Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases. Cancer 20.1121- 1745, 1967.
7. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539, 1996.
8. Bartelink H, Roelofsen F, Eschwege F, et al: Concomittant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049, 1997.
9. Beahrs OH, Wilson SM: Carcinoma of the anus. Aim Surg 184:422-428, 1976.
10. Frost DB, Richards PC, Montague ED, et al: Epidermoid cancer of the anorectum. Cancer 53:1285-1293, 1984.
11. Greenall MJ, Quan SH, Stearns MW, et al: Epidermoid cancer of the anal margin: Pathologic features, treatment, and clinical results. Am J Surg 149:95-101, 1985.
12. Pintor MP, Northover JM, Nicholls RJ: Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 76:806-810, 1989.
13. Boman BM, Moertel CG, O'Connell MJ, et al: Carcinoma of the anal canal: A clinical and pathologic study of 188 cases. Cancer 54:114-125, 1984.
14. Schlienger M, Krzisch C, Pene F, et al: Epidermoid carcinoma of the anal canal: Treatment results and prognostic variables in a series of 242 cases. Int J Radial Oncol Biol Phys 17:1141-1151, 1989.
15. Touboul E, Schlienger M, Buffat L, et al: Epidermoid carcinoma of the anal canal: Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73:1569-1579, 1994.
16. Klas JV, Rothenberger DA, Wong WD, et al: Malignant tumors of the anal canal: The spectrum of disease, treatment, and outcomes. Cancer 85:1686-1693, 1999.
17. Holly EA, Whittemore AS, Aston DA, et al: Anal cancer incidence: Genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 81:1726-1731, 1989.
18. Melbye M, Rabkin C, Frisch M, et al: Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 139:772-780, 1994.
19. Frisch M, Melbye M, Moller H: Trends in incidence of anal cancer in Denmark. Br Med 7 306:419-422, 1993.
20. Frisch M, Glimelius B, van den Brule AJ, et al: Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337:1350-1358, 1997.
21. Melbye M, Sprogel P: Aetiological parallel between anal cancer and cervical cancer. Lancet 338:657-659, 1991.
22. Frisch M, Olsen JH, Melbye M: Malignancies that occur before and after anal cancer: Clues to their etiology. Am J Epidemiol 140:12-19, 1994.
23. Rabkin CS, Biggar RJ, Melbye M, et al: Second primary cancers following anal and cervical carcinoma: Evidence of shared etiologic factors. Am J Epidemiol 136:54-58, 1992.
24. Palefsky JM, Holly EA, Hogeboom CJ, et al: Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV- positive and HIV-negative homosexual men. J Acqitir Immune Defic Syndr Hum Retroviral 17:314-319, 1998.
25. Palefsky JM, Holly EA, Ralston ML, et al: Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 17:320-326, 1998.
26. Sun XW, Kuhn L, Ellerbrock TV, et al: Human papillomavirus infection in women infected with the human immunodeficiency virus. N'Engl J Med 337:1343-1349, 1997.
27. Critchlow CW, Surawicz CM, Holmes KK, et al: Prosepective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 9:1255-1262, 1995.
28. Palefsky JM, Holly EA, Ralston ML, et al: Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HlV)-positive and HIV-negative homosexual men. J Infect Dis 177:361-367, 1998.
29. Frisch M, Biggar RJ, Goedert JJ: Human Papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500-1510, 2000.
30. International Collaboration on HIV and Cancer: Highly active antiretroviral therapy and the incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823-11083, 2000.
31. Goldie SJ, Kuntz KM, Weinstein MC, et al: The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281:1822-1829, 1999.
32. Goldie SJ, Kuntz KM, Weinstein MC, et al: Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 108:634-641, 2000.
33. Penn I: Incidence and treatment of neoplasia after transplantation. J Heart Lang Transplant 12:S328-336, 1993.
34. Penn I: Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 58:611-616, 1986.
35. Arends MJ, Benton EC, McLaren KM, et al: Renal allograft recipients with high susceptibility to cutaneuos malignancy have an increased prevalence of human papillomavirus DNA in skin tumors and a greater risk of anogenital malignancy. Br J Cancer 75:722-728, 1997.
36. Sillman FH, Stanek A, Sedlis A, et al: The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 150:300-308, 1984.
37. Sillman FH, Sedlis A: Anogenital papillomavirus infection and neoplasia in immuno- deficient women: An update. Dermatol Clin 9:353-369, 1991.
38. Sillman FH, Fruchter RG, Chen YS, et al: Vaginal intraepithelial neoplasi: Risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol 176:93-99, 1997.
39. Holmes F, Borek D, Owen-Kummer M, et al: Anal cancer in women. Gastroenterology 95:107-111, 1988.
40. Daling JR, Sherman KJ, Hislop TG, et al: Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135:180-189, 1992.
41. Singh R, Nime F, Mittleman A: Malignant epithelial tumors of the anal canal. Cancer 48:411-415, 1981.
42. Greenall MJ, Quan SH, Urmacher C, et al: Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 161:509-517, 1985.
43. Dougherty BG, Evans HL: Carcinoma of the anal canal: A study of 79 cases. Am J Clin Pathol 83:159-164, 1985.
44. Nigro ND, Vaitkevicius VK, Considine B Jr: Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 17:354-356, 1974.
45. Hughes LL, Rich TA, Delclos L, et al: Radiotherapy for anal cancer: Experience from 1979-1987. Int J Radial Oncol Biol Phys 17:1153-1160, 1989.
46. Cummings BJ, Keane TJ, O'Sullivan B, et al: Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorou- racil with and without mitomycin C. Int J Radial Oncol Biol Phys 21:1115-1125, 1991.
47. John M, Pajak T, Flam M, et al: Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J SciAm 2:205-211, 1996.
48. Doci R, Zucali R, Bombelli L, et al: Combined chemoradiation therapy for anal cancer: A report of 56 cases. Ann Surg 215:150-156, 1992.
49. Doci R, Zucali R, LaMonica G, et al: Primary chemoradiation therapy with fluorou- racil and cisplatin for cancer of the anus: Results in 35 consecutive patients. J Clin Oncol 14:3121-3125, 1996.
50. Sischy B, Dogett RL, Krall JM, et al: Definitive irradiation and chemotherapy forra- diosensitization in management of anal carcinoma: Interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 81:850-856, 1989.
51. Martenson JA, Lipsitz SR, Wagner H Jr, et al: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 35:745-749, 1996.
52. Martenson JA, Lipsitz SR, Lefkopoulou M, et al: Results of combined modality therapy for patients with anal cancer (E7283): An Eastern Cooperative Oncology Group study. Cancer 76:1731-1736, 1995.
53. Enker WE, Heilwell M, Janov AJ, et al: Improved survival in epidermoid carcinoma of the anus in association with preoperative mul- tidisciplinary therapy. Arch Surg 121:1386-1390, 1986.
54. Michaelson RA, Magill GB, Quan SH, et al: Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer 51:390-395, 1983.
55. Nigro ND: Multidisciplinary management of cancer of the anus. World J Surg 11:446-451, 1987.
56. Nigro ND, Seydel HG, Considine B, et al: Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 51:1826-1829, 1983.
57. Sischy B: The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus. and marginally respectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 11:1587-1593, 1985.
58. Sischy B, Remington, JH, Hinson, EI, et' al: Definitive treatment of anal-canal carcinoma by means of radiation therapy and chemotherapy. Dis Colon Rectum 25:685-688, 1982.
59. John MJ, Flam M, Lovalvo LJ, et al: Feasibility of non-surgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys 13:299-303, 1987.
60. Flam MS, John M, Lovalvo LI, et al: Definitive nonsurgical therapy of epithelial malignancies of the anal canal: Report of 12 cases. Cancer 51:1378-1387, 1983.
61. Cummings B, Keane T, Thomas G, et al: Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 54:2062-2068, 1984.
62. Fung CY, Willelt CG, Efird JT, et al: Chemoradiotherapy for anal carcinoma: What is the optimal radiation dose? Radiat Oncol Invest 2:152-156, 1994.
63. Johnson D, Lipsett J, Leong L, et al: Carcinoma of the anus treated with primary radiation therapy and chemotherapy. Surg Gynecol Obstet 177:329-334, 1993.
64. Meeker WR Jr, Sickle-Santanello BJ, Philpot G, et al: Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 57:525-529, 1986.
65. John M, Flam M, Palma N: Ten-year results of chemoradiation for anal cancer: Focus on late morbidity. Int J Radiat Oncol Biol Phys 34:65-69, 1996.
66. Nigh SS, Smalley SR, Elman AJ, et al: Conservative therapy for anal carcinoma: An analysis of prognostic factors. Int J Radiat Oncol Biol Phys 21(suppl 1):224, 1991.
67. Allal A, Kurtz JM, Pipard G, et al: Chemoradiotherapy versus radiotherapy alone for anal cancer: A retrospective comparison. Int J Radiat Oncol Biol Phys 27:59-66, 1993.
68. Tanum G, Tveit K, Karlsen KO, et al: Chemotherapy and radiation therapy for anal carcinoma: Survival and late morbidity. Cancer 67:2462-2466, 1991.
69. Chadha M, Rosenblatt EA, Malamud S, et al: Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 37:861-865, 1994.
70. Peddada AV, Smith DE, Rao AR, et al: Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 37:1101-1105, 1997.
71. Hoffman R, Welton ML, Klencke B, et al: The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV- positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44:127-131, 1999.
72. Puthawala AA, Syed AM, Gates TC, et al: Definitive treatment of extensive anorectal carcinoma by external and interstitial irradiation. Cancer 50:1746-1750.
73. Cummings BJ, Thomas GM, Keane TJ, et al: Primary radiation therapy in the treatment of anal canal carcinoma. Dis Colon Rectum 25:778-782, 1982.
74. Cantril ST, Green JP, Schall GL, et al: Primary radiation therapy in the treatment of anal carcinoma. Int J Radiat Oncol Biol Phys 9:1271-1278, 1983.
75. Papillon J, Mayer M, Montbafbon JF, et al: A new approach to the management of epidermoid carcinoma of the anal canal. Cancer 51:1830-1837, 1983.
76. Doggett SW, Green JP, Cantril ST: Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 15:1069-1072, 1988.
77. Hughes LL, Rich TA, Delclos L, et al: Radiotherapy for anal cancer: Experience from 1979-1987. Int J Radiat Oncol Biol Phys 17:1153-1160, 1989.
78. Cummings BJ, Keane TJ, O'SuIlivan B, et al: Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorou- racil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115-1125, 1991.
79. Dubois JB, Garrigues JM, Pujol H: Cancer of the anal canal: Report on the experience of 61 patients. Int J Radiat Oncol Biol Phys 20:575-580, 1991.
80. Martenson JA Jr, Gunderson, LL: External radiation therapy without chemotherapy in the management of anal cancer. Cancer 71:1736-1740, 1993.
81. Eschwedge F, Lasser P, Chavy A, et al: Squamous cell carcinoma of the anal canal: Treatment by external beam radiation. Radiother Oncol 3:145-150, 1985.
82. UKCCCR Anal Cancer Trial Working Party: Epidermoid anal cancer: Results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049-1054, 1996.
83. Kantarjian HM, Keating MJ, Walters RS, et al: Therapy-related leukemia and myelodys- plastic syndrome: Clinical, cytogenetic, and prognostic features. J Clin Oncol 4:1748-1757, 1986.
84. Pedersen-Bjergaard J, Philip P, Larsen SO, et al: Therapy-related myelodysplasia and acute myeloid leukemia: Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant disease in the Copenhagen series. Leukemia 7:1975-1986, 1993.
85. Doci R, Zucali R, LaMonica G, et al: Primary chemoradiation therapy with fluorou-racil and cisplatin for cancer of the anus: Results in 35 consecutive patients. J Clin Oncol 14:3121-3125, 1996.
86. Martenson JA, Lipsitz SR, Wagner H Jr, et al: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 35:745-749, 1996.
87. Peiffert D, Giovanni M, Ducreaux M, et al: High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5- fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study. Ann Oncol 12:397-404, 2001.
88. Gerard JP, Ayzac L, Hun D, et al: Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil- cisplatinum. Long-term results in 95 patients. Radiother Oncol 46:249-256, 1998.
89. Javier A, Curcio E, Perez J, et al: Induction 5-fluorouracil (5-FU)/cisplatin (CP) followed by combined external beam radiation therapy (XRT) and chemotherapy in locally advanced anal canal cancer ( 1181). Proc Am Soc Clin Oncol 19:301a, 2000.
90. Meropol NJ, Niedzwiecki D, Shank B, et al: Combined-modality therapy of poor risk anal canal carcinoma: A phase II study of the Cancer and Leukemia Group B (CALGB) (abstract 909). Proc Am Soc Clin Oncol 18:237a, 1999.
91. Pocard M, Tiret E, Nugent K, et al: Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 41:1488-1493, 1998.
92. Allal AS, Laurencet FM, Reymond MA, et al: Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 85:1686-1693, 1999.
93. Klas JV, Rothenberger DA, Wong WD, et al: Malignant tumors of the anal canal: The spectrum of disease, treatment, and outcomes. Cancer 86:405-409, 1999.
94. Zimm S, Wampler GL: Response of metastatic cloacogenic carcinoma to treatment with sestamustine. Cancer 48:2575-2576, 1981.
95. Khater R, Frenay M, Bourry J, et al: Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: A report of two cases. Cancer Treat Rep 70:1345-1346, 1986.
96. Ajani JA, Carrasco CH, Jackson DE, et al: Combination of cisplatin plus fluoropyrimi- dine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 87:221-224, 1989.